Anika Therapeutics, Inc. (ANIK) vs OraSure Technologies, Inc. (OSUR)
A side-by-side comparison of Anika Therapeutics, Inc. and OraSure Technologies, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ANIK
Anika Therapeutics, Inc.
$19.16HealthcareDelayed quote: Oct 6, 2026, 2:29 PM EDT
OSUR
OraSure Technologies, Inc.
$3.80HealthcareDelayed quote: Oct 6, 2026, 2:25 PM EDT
Total return — ANIK vs OSUR
growth of $100 · dividends reinvested · last 10yANIK -55.7% (-7.8%/yr)OSUR -46.7% (-6.1%/yr)OSUR compounded faster over this window
ANIK OSUR
ANIK vs OSUR: by the numbers
- •OSUR is the larger company ($262M vs $256M market cap).
- •Both run net losses; ANIK's is the smaller (-3.14% vs -43.70% net margin).
- •Both shrank revenue over the past five years; ANIK's decline was smaller (-2.48% vs -13.12% CAGR).
Metrics side by side
Valuation
| Metric | ANIK | OSUR |
|---|---|---|
| Forward P/E | 18.25 | N/A |
| P/S ratio | 2.13 | 2.33 |
| P/B ratio | 1.87 | 0.82 |
| EV / EBITDA | 474.07 | N/A |
| FCF yield | 0.22% | N/A |
Profitability
| Metric | ANIK | OSUR |
|---|---|---|
| Gross margin | 62.16% | 41.38% |
| Operating margin | -4.24% | -59.23% |
| Net margin | -3.14% | -43.70% |
| ROE | -2.76% | -15.46% |
| ROIC | -3.17% | -15.00% |
Growth (annualized)
| Metric | ANIK | OSUR |
|---|---|---|
| Revenue CAGR (5Y) | -2.48% | -13.12% |
| FCF CAGR (5Y) | -39.38% | N/A |
| Total return CAGR (5Y) | -13.40% | -17.56% |
Frequently asked
- Which has grown faster, ANIK or OSUR?
- Neither grew: over the past five years both shrank revenue, with ANIK's decline the smaller — ANIK at a -2.48% CAGR versus OSUR at -13.12%.
- How have ANIK and OSUR total returns compared?
- Over the past 10 years, ANIK delivered -8.51% and OSUR delivered -6.51% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.